806 related articles for article (PubMed ID: 6154062)
1. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
Trachtenberg J; Hicks LL; Walsh PC
J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor content of nafoxidine treated experimentally induced canine prostatic hyperplasia.
Trachtenberg J
Clin Invest Med; 1985; 8(1):29-34. PubMed ID: 2580656
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor content of the normal and hyperplastic canine prostate.
Shain SA; Boesel RW
J Clin Invest; 1978 Mar; 61(3):654-60. PubMed ID: 76635
[TBL] [Abstract][Full Text] [Related]
4. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
5. Effect of endocrine manipulations on the levels of cytosolic and nuclear receptors for androgens in dog prostate.
Dube JY; Frenette G; Tremblay RR
Invest Urol; 1981 May; 18(8):418-21. PubMed ID: 7228574
[TBL] [Abstract][Full Text] [Related]
6. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
7. Immunolocalization of androgen receptors, estrogen alpha receptors, and estrogen beta receptors in experimentally induced canine prostatic hyperplasia.
Gallardo F; Lloreta J; García F; Moll X; Baró T; González LA; Morote J; Reventos J; Mogas T
J Androl; 2009; 30(3):240-7. PubMed ID: 19136389
[TBL] [Abstract][Full Text] [Related]
8. Histochemical studies of epithelial cell glycoconjugates in atrophic, metaplastic, hyperplastic, and neoplastic canine prostate.
Orgad U; Alroy J; Ucci A; Merk FB
Lab Invest; 1984 Mar; 50(3):294-302. PubMed ID: 6199584
[TBL] [Abstract][Full Text] [Related]
9. Concentration of dihydrotestosterone and 3 alpha-androstanediol in naturally occurring and androgen-induced prostatic hyperplasia in the dog.
Moore RJ; Gazak JM; Quebbeman JF; Wilson JD
J Clin Invest; 1979 Oct; 64(4):1003-10. PubMed ID: 90055
[TBL] [Abstract][Full Text] [Related]
10. The induction of prostatic hypertrophy in the dog with androstanediol.
Walsh PC; Wilson JD
J Clin Invest; 1976 Apr; 57(4):1093-7. PubMed ID: 59740
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural and biochemical expressions of divergent differentiation in prostates of castrated dogs treated with estrogen and androgen.
Merk FB; Ofner P; Kwan PW; Leav I; Vena RL
Lab Invest; 1982 Nov; 47(5):437-50. PubMed ID: 6182388
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol.
Moore RJ; Gazak JM; Wilson JD
J Clin Invest; 1979 Mar; 63(3):351-7. PubMed ID: 219036
[TBL] [Abstract][Full Text] [Related]
13. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
Ho SM; Yu M
Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
[TBL] [Abstract][Full Text] [Related]
14. Hormone sensitivity of the R3327-G rat prostate adenocarcinoma: growth rate, DNA content, and hormone receptors.
Pollack A; Irvin GL; Block NL; Lipton RM; Stover BJ; Claflin AJ
Cancer Res; 1982 Jun; 42(6):2184-90. PubMed ID: 7074599
[TBL] [Abstract][Full Text] [Related]
15. Possible mechanism of induction of benign prostatic hyperplasia by estradiol and dihydrotestosterone in dogs.
Winter ML; Liehr JG
Toxicol Appl Pharmacol; 1996 Feb; 136(2):211-9. PubMed ID: 8619228
[TBL] [Abstract][Full Text] [Related]
16. Morphometric analysis of prostates in castrated dogs after treatment with androstanediol, estradiol, and cyproterone acetate.
Tunn UW; Schüring B; Senge T; Neumann F; Schweikert HU; Rohr HP
Invest Urol; 1981 Jan; 18(4):289-92. PubMed ID: 6161104
[TBL] [Abstract][Full Text] [Related]
17. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta.
Ho SM; Leav I; Merk FB; Yu M; Kwan PW; Ziar J
Lab Invest; 1995 Sep; 73(3):356-65. PubMed ID: 7564268
[TBL] [Abstract][Full Text] [Related]
18. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
[TBL] [Abstract][Full Text] [Related]
19. Expression of androgen, oestrogen alpha and beta, and progesterone receptors in the canine prostate: differences between normal, inflamed, hyperplastic and neoplastic glands.
Gallardo F; Mogas T; Baró T; Rabanal R; Morote J; Abal M; Reventós J; Lloreta J
J Comp Pathol; 2007 Jan; 136(1):1-8. PubMed ID: 17078963
[TBL] [Abstract][Full Text] [Related]
20. Effect of hormone injections on levels of cytosolic receptors for estrogen, androgen and progesterone in dog prostate.
Frenette G; Dube JY; Tremblay RR
J Steroid Biochem; 1982 Sep; 17(3):271-6. PubMed ID: 6290786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
